Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency V...
Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy
About this item
Full title
Author / Creator
Publisher
Chicago, IL: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Chicago, IL: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
Morphologic and metabolic changes associated with protease inhibitor (PI) therapy have been reported since the introduction of PIs for treatment of human immunodeficiency virus infection. These changes were measured 12–20 months after initiation of PI therapy in a cross-sectional study involving 614 patients from the Antiprotéases Cohorte (APROCO)...
Alternative Titles
Full title
Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_18465178
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18465178
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1086/339866
